With the New Year upon us, we – the FindMeCure team – look ahead at all the challenges we want to tackle in 2018, all the people we can help this year and all the possibilities the future holds for people searching for a cure, with all the clinical trials developing new treatments and therapies and all the medical research going on ever so strongly. But we also turn our gaze backward, to the past 12 months on the blog, and consider the most read blog posts for 2017 and the topics we have covered so far.

It wasn’t easy to predict what the most read posts from the past year were going to be. Our readers seem to have quite the eclectic taste or as chance would have it, there are numerous topics searched for on the internet. So, without further ado here are the top 5 most read articles on the FindMeCure blog

  “How to Get Innovative Treatment When You Don’t Qualify For The Clinical Trial” is a post from the 25th of August, which opens up the discussion of “expanded access” (also found under “compassionate use” or “pre-approval access”). Expanded access is “when an investigational drug is used outside of a clinical trial when there are people with life-threatening conditions who can’t enroll into the clinical trial because they don’t meet the criteria” and to learn more about it, we recommend reading the whole article and sending it to someone who might need it. It also goes into that “but what if I don’t qualify for expanded access either?” territory and gives you some info about what “single patient access” means.

 “The Most Important on Stomach Cancer in a Nutshell (Part 1)” is from the 16th of June and it made the 4th place on our most-read list. It gives basic information about what stomach cancers is, what the symptoms are, what the risk factors and potential causes are, what treatments there are and how to find stomach cancer clinical trials that may work for you.

 “Stomach Cancer: Know The Enemy” is another stomach cancer article that made it on the list. It’s from the 15th of May and it’s dedicated to the World Digestive Health Day, which was on the 29th of May. The article opens up with some statistics like: “The average risk that a person will develop gastric cancer in their lifetime is approximately 1 in 111”, and it reminds us what the 5 leading behavioral risks for cancer are – tobacco use, alcohol use, high body mass index and low vegetable and fruit intake.

“Make a Step, Cross the Bridge to Drugs of the Future Now” takes the second place on FindMeCure’s list. This post from the 3rd of February is both a kind of a short manifesto, stating what we believe in and what our mission is, and a call for you to help us make the FindMeCure platform more accessible and easy to navigate, by filling in a questionnaire which by the way is still available. It’s a small gesture of support but we believe that “small things can make big difference”.

Aaaand the most read FindMeCure blog post for 2017 is “Why Rheumatoid Arthritis is Vastly Different Than Arthritis”.  It’s from the 24th of October it gives some information about rheumatoid arthritis and what makes the difference between it and other forms of arthritis (it affects other organs too, not just the skeletal system). RA is an autoimmune inflammatory disease and as such, it doesn’t contain itself in only one part of the body like OA does. If you’re interested in reading more about RA, we have some more articles on it on the blog, including one post about drugs in development.

More about RA

So, here there are – the 5 most read posts on the blog for 2017. We hope your retrospection over the past one year was as productive and enlightening as ours. Now, take a moment to plan for the future and most of all – enjoy the present as you can never repeat the moment. We’ll see you in 2018!

 

On the article worked: Nelly Katsarova

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Close